← Back to Clinical Trials
Recruiting NCT00280202

Detection of Genetic Markers of Lung Cancer

Trial Parameters

Condition Lung Cancer
Sponsor University of Pittsburgh
Study Type OBSERVATIONAL
Phase N/A
Enrollment 6,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 1996-06
Completion 2050-12
Interventions
Biopsy of the major carinal areaBiopsy of abnormal & suspicious areas of the bronchial treeEvaluation of the tumor for DNA mutations

Brief Summary

The purpose of this research study is to determine the genetic changes and immunologic changes that are involved in the development and progression of bronchogenic lung cancer.

Eligibility Criteria

Inclusion Criteria: * Histologic confirmation of lung cancer, lung metastases from a primary site other than lung, mesothelioma or a radiographic lesion highly suspicious for malignancy * Written informed consent. * To be scheduled for a biopsy or surgical resection or have already had a biopsy and/or surgical removal of a lung mass Exclusion Criteria: None

Related Trials